ZA9510901B - Tricyclic oxime ethers processes for their preparation and pharmaceutical compositions containing them - Google Patents

Tricyclic oxime ethers processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA9510901B
ZA9510901B ZA9510901A ZA9510901A ZA9510901B ZA 9510901 B ZA9510901 B ZA 9510901B ZA 9510901 A ZA9510901 A ZA 9510901A ZA 9510901 A ZA9510901 A ZA 9510901A ZA 9510901 B ZA9510901 B ZA 9510901B
Authority
ZA
South Africa
Prior art keywords
substd
opt
alkyl
phenyl
cycloalkyl
Prior art date
Application number
ZA9510901A
Other languages
English (en)
Inventor
Sylvain Rault
Max Robba
Jean-Charles Lancelot
Herve Prunier
Pierre Renard
Bruno Pfeiffer
Beatrice Guardiola-Lemaitre
Marie-Claire Rettori
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA9510901B publication Critical patent/ZA9510901B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
ZA9510901A 1994-12-22 1995-12-21 Tricyclic oxime ethers processes for their preparation and pharmaceutical compositions containing them ZA9510901B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415431A FR2728571B1 (fr) 1994-12-22 1994-12-22 Nouveaux ethers d'oximes tricycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA9510901B true ZA9510901B (en) 1996-06-24

Family

ID=9470078

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9510901A ZA9510901B (en) 1994-12-22 1995-12-21 Tricyclic oxime ethers processes for their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US5627203A (es)
EP (1) EP0718299B1 (es)
JP (1) JP2937837B2 (es)
CN (2) CN1066449C (es)
AT (1) ATE191483T1 (es)
AU (1) AU693615B2 (es)
CA (1) CA2165618C (es)
DE (1) DE69516100T2 (es)
DK (1) DK0718299T3 (es)
ES (1) ES2147271T3 (es)
FI (1) FI956136A (es)
FR (1) FR2728571B1 (es)
GR (1) GR3033507T3 (es)
NO (1) NO955215L (es)
NZ (1) NZ280734A (es)
PT (1) PT718299E (es)
ZA (1) ZA9510901B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2781482B1 (fr) * 1998-07-27 2001-08-31 Adir Nouveaux derives de 8h-thieno-[2,3-b]pyrrolizine-8-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7241803B2 (en) * 2002-11-21 2007-07-10 New York Blood Center Compounds for inhibition of HIV infection by blocking HIV entry
DE102008015032A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte Pyrazolamide und ihre Verwendung
DE102008015033A1 (de) * 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung
DE102008062878A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte Furancarboxamide und ihre Verwendung
DE102008062863A1 (de) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE371193B (es) * 1972-03-24 1974-11-11 Kabi Ab
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4134894A (en) * 1978-05-04 1979-01-16 Warner-Lambert Company Pyrrolo[1,2-a]indole compounds
HU180739B (en) * 1979-07-03 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing basic oxime-ethers
US5128364A (en) * 1991-03-28 1992-07-07 Merck Frosst Canada, Inc. Pyrrolo[1,2-a]indole hydroxylamine derivatives as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
CA2165618A1 (fr) 1996-06-23
ES2147271T3 (es) 2000-09-01
NO955215D0 (no) 1995-12-21
DE69516100T2 (de) 2000-12-14
JP2937837B2 (ja) 1999-08-23
AU4059395A (en) 1996-06-27
US5627203A (en) 1997-05-06
AU693615B2 (en) 1998-07-02
DE69516100D1 (de) 2000-05-11
GR3033507T3 (en) 2000-09-29
ATE191483T1 (de) 2000-04-15
NZ280734A (en) 1997-09-22
JPH08231554A (ja) 1996-09-10
FR2728571A1 (fr) 1996-06-28
NO955215L (no) 1996-06-24
EP0718299B1 (fr) 2000-04-05
DK0718299T3 (da) 2000-09-04
FI956136A0 (fi) 1995-12-20
CA2165618C (fr) 2001-04-10
CN1066449C (zh) 2001-05-30
EP0718299A1 (fr) 1996-06-26
PT718299E (pt) 2000-07-31
FI956136A (fi) 1996-06-23
CN1261073A (zh) 2000-07-26
FR2728571B1 (fr) 1997-01-31
CN1131155A (zh) 1996-09-18

Similar Documents

Publication Publication Date Title
HUT70423A (en) Oxazolidine derivatives, process for preparing them and pharmaceutical compositions containing them
EP0632031A4 (es)
ZA9510901B (en) Tricyclic oxime ethers processes for their preparation and pharmaceutical compositions containing them
ZA985501B (en) Chromene compounds a process for their preparation and pharmaceutical compositions containing them
ES460286A1 (es) Un procedimiento de preparacion de espiro(1,3-dioxolan-4,3) quinuclidina.
AU1498895A (en) Novel aminoalkyl benzoazolinones and benzothiazolinones, process for their preparation and the pharmaceutical compositions which contain them
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
ES8305359A1 (es) Un procedimiento para la preparacion de benzamitas sustituidas.
MY101380A (en) An ether compound, its production and an insecticidal and acaricidal composition containing it as an active ingredient
ES8207137A1 (es) Procedimiento de preparacion de nuevos derivados biciclo (2.2.1)heptanos.
ZA969412B (en) Tetracyclic 1,4-oxazine compounds a process for their preparation and pharmaceutical compositions containing them
GR3036192T3 (en) Thiophene compounds, process for their preparation and pharmaceutical compositions containing them
NO981566L (no) Nye aminoforbindelser av 6,7,8,9-tetrahydro-cyklopenta[a]naftalen og av 2,3-dihydro-cyklopenta[e]inden, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger som inneholder dem
IL101379A0 (en) Light screening compositions containing isoxazolones,certain such novel compounds and their preparation
AU1494295A (en) Novel aminoalkyl benzothiazolinones, process for their preparation and the pharmaceutical compositions which contain them
ES8400445A1 (es) "un procedimiento para la preparacion de compuestos de isocianuro-triorganoestano".
ES8401040A1 (es) Procedimiento para la obtencion de azoliletil-oximinoalquil-eteres.
GB1104609A (en) Basic oximes and their preparation